Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity.

Raymond T. Kraker,David K. Wallace,Roy W. Beck,Christina T. Saunders,Elizabeth Lorenzi,B. Michele Melia,Zhuokai Li,Sharon F. Freedman,Sasapin G. Prakalapakorn,Sarah K. Jones,David A. Nasrazadani,Ann Martin Cranford,Beth McLendon Arvik,Mary Miller-Bell,Catherine S. Sampey,Barbara K. Wiernek,Earl R. Crouch,Gaylord G. Ventura,James E. Dice,Amy K. Hutchinson,G. Baker Hubbard,Joshua E. Robinson,Judy Brower,Xi-Juan Chen,James E. Rhodes,David L. Rogers,Don L. Bremer,Richard P. Golden,Catherine O. Jordan,Mary Lou McGregor,Rachel E. Reem,Sara Ann Maletic,Meghan C. McMillin,Rachel Tobe Miller,Jill E. Bind,Julie A. Leary,Regina M. Mhaskar,Teresa L. Stiltner,Michael B. Yang,Eniolami O. Dosunmu,Michael E. Gray,William W. Motley,Terry L. Schwartz,Patricia Cobb,Patricia Hirsch,Melissa Reed,Denise Lagory,Steven Topmiller,David K. Coats,Amit R. Bhatt,Ann B. Demny,Lingkun Kong,Vanessa K. Bui,Jennifer L. Lynds,Tara P. McCartney,Deborah K. VanderVeen,Jason S. Mantagos,Carolyn Wu,Grace Yoon,Samantha Goldstein,Tamar Winter,Rocco Anzaldi,Charline S. Boente,Heather A. Smith,Kathyrn M. Haider,Elizabeth A. Hynes,Melissa Allard,Annette Head,David Morse,R. Michael Siatkowski,Janine E. Collinge,Kelli Satnes,Michelle H. Blunt,Kaci D. Taylor,Mary Elizabeth Hartnett,David C. Dries,Robert O. Hoffman,Katie Jo Farnsworth,Susan Sorenson,Darrell S. Austin,Nicole M. Boyle,Patricia L. Connelly,Courtney L. Conner,Danielle L. Chandler,Quayleen Donahue,Brooke P. Fimbel,Robert J. Henderson,Amra Hercinovic,James E. Hoepner,Joseph D. Kaplon,Gillaine Ortiz,Julianne L. Robinson,Kathleen M. Stutz,David O. Toro,Victoria C. Woodard,Rui Wu,Donald F. Everett,William F. Astle,Eileen E. Birch,Angela M. Chen,Susan A. Cotter,Laura B. Enyedi,S. Ayse Erzurum,Jonathan M. Holmes,Scott R. Lambert,Katherine A. Lee,Vivian A. Manh,Ruth E. Manny,Michael X. Repka,Jayne L. Silver,Katherine K. Weise,Lisa C. Verderber,Marie Diener-West,John D. Baker,Barry R. Davis,Dale L. Phelps,Stephen W. Poff,Richard A. Saunders,Lawrence Tychsen

Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity.

2021

Raymond T. Kraker
David K. Wallace
Roy W. Beck
Christina T. Saunders
Elizabeth Lorenzi
B. Michele Melia
Zhuokai Li
Sharon F. Freedman
Sasapin G. Prakalapakorn
Sarah K. Jones
David A. Nasrazadani
Ann Martin Cranford
Beth McLendon Arvik
Mary Miller-Bell
Catherine S. Sampey
Barbara K. Wiernek
Earl R. Crouch
Gaylord G. Ventura
James E. Dice
Amy K. Hutchinson
G. Baker Hubbard
Joshua E. Robinson
Judy Brower
Xi-Juan Chen
James E. Rhodes
David L. Rogers
Don L. Bremer
Richard P. Golden
Catherine O. Jordan
Mary Lou McGregor
Rachel E. Reem
Sara Ann Maletic
Meghan C. McMillin
Rachel Tobe Miller
Jill E. Bind
Julie A. Leary
Regina M. Mhaskar
Teresa L. Stiltner
Michael B. Yang
Eniolami O. Dosunmu
Michael E. Gray
William W. Motley
Terry L. Schwartz
Patricia Cobb
Patricia Hirsch
Melissa Reed
Denise Lagory
Steven Topmiller
David K. Coats
Amit R. Bhatt
Ann B. Demny
Lingkun Kong
Vanessa K. Bui
Jennifer L. Lynds
Tara P. McCartney
Deborah K. VanderVeen
Jason S. Mantagos
Carolyn Wu
Grace Yoon
Samantha Goldstein
Tamar Winter
Rocco Anzaldi
Charline S. Boente
Heather A. Smith
Kathyrn M. Haider
Elizabeth A. Hynes
Melissa Allard
Annette Head
David Morse
R. Michael Siatkowski
Janine E. Collinge
Kelli Satnes
Michelle H. Blunt
Kaci D. Taylor
Mary Elizabeth Hartnett
David C. Dries
Robert O. Hoffman
Katie Jo Farnsworth
Susan Sorenson
Darrell S. Austin
Nicole M. Boyle
Patricia L. Connelly
Courtney L. Conner
Danielle L. Chandler
Quayleen Donahue
Brooke P. Fimbel
Robert J. Henderson
Amra Hercinovic
James E. Hoepner
Joseph D. Kaplon
Gillaine Ortiz
Julianne L. Robinson
Kathleen M. Stutz
David O. Toro
Victoria C. Woodard
Rui Wu
Donald F. Everett
William F. Astle
Eileen E. Birch
Angela M. Chen
Susan A. Cotter
Laura B. Enyedi
S. Ayse Erzurum
Jonathan M. Holmes
Scott R. Lambert
Katherine A. Lee
Vivian A. Manh
Ruth E. Manny
Michael X. Repka
Jayne L. Silver
Katherine K. Weise
Lisa C. Verderber
Marie Diener-West
John D. Baker
Barry R. Davis
Dale L. Phelps
Stephen W. Poff
Richard A. Saunders
Lawrence Tychsen

This study determines which of 8 doses of bevacizumab are effective in treating severe retinopathy of prematurity to carry forward to a large-scale randomized clinical trial.

Keywords:

Bevacizumab
Randomized controlled trial
dose level
low dose
Retinopathy of prematurity
Laser
Urology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations